Whatever your IT is –

Start IT with XYNTHA^® SOLOFUSE^®

play

Home

Demonstrated to prevent and control bleeds—
XYNTHA SOLOFUSE helps prepare you to live actively

Proven bleed control

When you need it. Demonstrated across clinical trials of previously treated patients (PTPs).

All-in-one reconstitution

Be prepared to bring it—Preparation with all-in-one reconstitution and a travel-ready kit.

Free trial offer*

Find out if you're eligible to receive a
one-time, 1-month supply up to 20,000 IU of XYNTHA at no cost.

*Terms and conditions apply.

Tools and resources

More than just factor—Take a look at some of the tools and resources Pfizer Hemophilia has to offer.

Environmentally friendly
travel-ready kit

The cardboard travel-ready kit still comes compact and loaded with everything you need to infuse on the go.

Important Safety Information for XYNTHA

Call your healthcare provider or go to the emergency department right away if you have any of the following symptoms because these may be signs of a serious allergic reaction: wheezing, difficulty breathing, chest tightness, turning blue (look at lips and gums), fast heartbeat, swelling of the face, faintness, rash, low blood pressure, or hives. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins. Tell your healthcare provider if you have had an allergic reaction to hamster protein
Call your healthcare provider right away if bleeding is not controlled after using XYNTHA; this may be a sign of an inhibitor, an antibody that may stop XYNTHA from working properly. Your healthcare provider may need to take blood tests to monitor for inhibitors
Across all clinical studies, the most common side effects (10% or more) with XYNTHA in adult and pediatric previously treated patients (PTPs) were headache (26% of subjects), joint pain (25%), fever (21%), and cough (11%). Other side effects reported in 5% or more of patients were: diarrhea, vomiting, weakness, and nausea
XYNTHA is an injectable medicine administered by intravenous (IV) infusion. You may experience local irritation when infusing XYNTHA after reconstitution in XYNTHA^® SOLOFUSE^®.

What is XYNTHA?

XYNTHA^® Antihemophilic Factor (Recombinant) is indicated in adults and children for the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for the prevention of bleeding during surgery in patients with hemophilia A.

XYNTHA does not contain von Willebrand factor and, therefore, is not indicated for von Willebrand’s disease.

Please see full Prescribing Information for XYNTHA and XYNTHA SOLOFUSE.

Patients should always ask their doctors for medical advice about adverse events.
You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The health information in this site is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed in this site may have different product labeling in different countries.

February 2018

AdChoices

PP-XYN-USA-0264-01